Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib + Paclitaxel in HER2+ Metastatic Breast Cancer
NCT00281658Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2006
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by Novartis. Started Jan 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00281658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281658.